Head and neck squamous cell carcinoma
DE Johnson, B Burtness, CR Leemans… - Nature reviews Disease …, 2020 - nature.com
Most head and neck cancers are derived from the mucosal epithelium in the oral cavity,
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and …
Squamous cell carcinoma of the head and neck (SCCHN) arises from epithelial cells and
occurs in the oral cavity, pharynx and larynx. Nasopharyngeal carcinoma (NPC) is a disease …
occurs in the oral cavity, pharynx and larynx. Nasopharyngeal carcinoma (NPC) is a disease …
Comprehensive management of HPV‐related squamous cell carcinoma of the head and neck of unknown primary
E Rassy, P Nicolai, N Pavlidis - Head & Neck, 2019 - Wiley Online Library
Background Human papillomavirus (HPV)‐related squamous cell carcinoma of unknown
primary (SCCUP) is currently rising in incidence but lacks a validated management …
primary (SCCUP) is currently rising in incidence but lacks a validated management …
Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO guideline
E Maghami, N Ismaila, A Alvarez… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide evidence-based recommendations to practicing physicians and other
health care providers on the diagnosis and management of squamous cell carcinoma of …
health care providers on the diagnosis and management of squamous cell carcinoma of …
Robotic surgery: an evolution in practice
Robotic surgery: an evolution in practice | Journal of Surgical Protocols and Research
Methodologies | Oxford Academic Skip to Main Content Advertisement Oxford Academic …
Methodologies | Oxford Academic Skip to Main Content Advertisement Oxford Academic …
[HTML][HTML] Transoral tongue base mucosectomy for the identification of the primary site in the work-up of cancers of unknown origin: systematic review and meta-analysis
S Farooq, S Khandavilli, J Dretzke, D Moore… - Oral oncology, 2019 - Elsevier
Background The use of transoral robotic surgery (TORS) and laser microsurgery (TLM) in
the diagnosis and identification of the site of the unknown primary has become increasingly …
the diagnosis and identification of the site of the unknown primary has become increasingly …
Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations
RM Baskin, BJ Boyce, R Amdur… - Cancer management …, 2018 - Taylor & Francis
The increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) emphasizes
the importance of optimizing treatment for the disease. Historical protocol has utilized …
the importance of optimizing treatment for the disease. Historical protocol has utilized …
[HTML][HTML] An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging
Early and accurate identification of head and neck squamous cell carcinoma (HNSCC) is
important to improve treatment outcomes and prognosis. New optical imaging techniques …
important to improve treatment outcomes and prognosis. New optical imaging techniques …
Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary cancer: management in the HPV era
FJ Civantos, JB Vermorken, JP Shah, A Rinaldo… - Frontiers in …, 2020 - frontiersin.org
Background Patients with metastases in the lymph nodes of the neck and no obvious
primary tumor, neck cancer with unknown primary (NCUP), represent a management …
primary tumor, neck cancer with unknown primary (NCUP), represent a management …
Transoral robotic surgery for head and neck cancer: advances and residual knowledge gaps
MH Mella, E Chabrillac, A Dupret-Bories… - Journal of Clinical …, 2023 - mdpi.com
Minimally invasive surgery is a growing field in surgical oncology. After acquiring its first
Food and Drug Administration approval in 2009 for T1–T2 malignancies of the oral cavity …
Food and Drug Administration approval in 2009 for T1–T2 malignancies of the oral cavity …